BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 33087928)

  • 1. TGF-β suppresses type 2 immunity to cancer.
    Liu M; Kuo F; Capistrano KJ; Kang D; Nixon BG; Shi W; Chou C; Do MH; Stamatiades EG; Gao S; Li S; Chen Y; Hsieh JJ; Hakimi AA; Taniuchi I; Chan TA; Li MO
    Nature; 2020 Nov; 587(7832):115-120. PubMed ID: 33087928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer immunotherapy via targeted TGF-β signalling blockade in T
    Li S; Liu M; Do MH; Chou C; Stamatiades EG; Nixon BG; Shi W; Zhang X; Li P; Gao S; Capistrano KJ; Xu H; Cheung NV; Li MO
    Nature; 2020 Nov; 587(7832):121-125. PubMed ID: 33087933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversion of the immune response to Neisseria gonorrhoeae from Th17 to Th1/Th2 by treatment with anti-transforming growth factor β antibody generates immunological memory and protective immunity.
    Liu Y; Russell MW
    mBio; 2011; 2(3):e00095-11. PubMed ID: 21610119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
    Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
    Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway.
    Grainger JR; Smith KA; Hewitson JP; McSorley HJ; Harcus Y; Filbey KJ; Finney CA; Greenwood EJ; Knox DP; Wilson MS; Belkaid Y; Rudensky AY; Maizels RM
    J Exp Med; 2010 Oct; 207(11):2331-41. PubMed ID: 20876311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells prime in vivo alloreactive CD4 T lymphocytes toward type 2 cytokine- and TGF-beta-producing cells in the absence of CD8 T cell activation.
    Foucras G; Coudert JD; Coureau C; Guéry JC
    J Immunol; 2000 Nov; 165(9):4994-5003. PubMed ID: 11046027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta1 enhances the interferon-gamma-dependent, interleukin-12-independent pathway of T helper 1 cell differentiation.
    Smeltz RB; Chen J; Shevach EM
    Immunology; 2005 Apr; 114(4):484-92. PubMed ID: 15804285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-derived TGF-β inhibits mitochondrial respiration to suppress IFN-γ production by human CD4
    Dimeloe S; Gubser P; Loeliger J; Frick C; Develioglu L; Fischer M; Marquardsen F; Bantug GR; Thommen D; Lecoultre Y; Zippelius A; Langenkamp A; Hess C
    Sci Signal; 2019 Sep; 12(599):. PubMed ID: 31530731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunoregulatory effects of gangliosides involve immune deviation favoring type-2 T cell responses.
    Crespo FA; Sun X; Cripps JG; Fernandez-Botran R
    J Leukoc Biol; 2006 Mar; 79(3):586-95. PubMed ID: 16415169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of allergic airway inflammation in a mouse model by Der p2 recombined BCG.
    Ou-Yang HF; Hu XB; Ti XY; Shi JR; Li SJ; Qi HW; Wu CG
    Immunology; 2009 Sep; 128(1 Suppl):e343-52. PubMed ID: 19191902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells.
    Zhang Q; Jang TL; Yang X; Park I; Meyer RE; Kundu S; Pins M; Javonovic B; Kuzel T; Kim SJ; Van Parijs L; Smith N; Wong L; Greenberg NM; Guo Y; Lee C
    Prostate; 2006 Feb; 66(3):235-47. PubMed ID: 16173028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraperitoneal Echinococcus multilocularis infection in mice modulates peritoneal CD4+ and CD8+ regulatory T cell development.
    Mejri N; Müller N; Hemphill A; Gottstein B
    Parasitol Int; 2011 Jan; 60(1):45-53. PubMed ID: 20965274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preventive and therapeutic effects of rapamycin against autoimmune hepatitis and liver fibrosis and possible mechanisms].
    Li WW; Sun P; Chen DD; Wang WQ; Jiao GH; Wang YJ; Zhou L; Wang BM; Zhang J
    Zhonghua Gan Zang Bing Za Zhi; 2016 May; 24(5):368-74. PubMed ID: 27470891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0.
    Barnard A; Mahon BP; Watkins J; Redhead K; Mills KH
    Immunology; 1996 Mar; 87(3):372-80. PubMed ID: 8778021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The timing of TGF-β inhibition affects the generation of antigen-specific CD8+ T cells.
    Quatromoni JG; Suzuki E; Okusanya O; Judy BF; Bhojnagarwala P; Venegas O; Eruslanov E; Predina JD; Albelda SM; Singhal S
    BMC Immunol; 2013 Jul; 14():30. PubMed ID: 23865808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-derived transforming growth factor-β is critical for tumor progression and evasion from immune surveillance.
    Li Z; Zhang LJ; Zhang HR; Tian GF; Tian J; Mao XL; Jia ZH; Meng ZY; Zhao LQ; Yin ZN; Wu ZZ
    Asian Pac J Cancer Prev; 2014; 15(13):5181-6. PubMed ID: 25040972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
    Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J
    J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
    Link J
    Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of CD4
    Anuradha R; Munisankar S; Bhootra Y; Dolla C; Kumaran P; Nutman TB; Babu S
    Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28874444
    [No Abstract]   [Full Text] [Related]  

  • 20. Blockade of transforming growth factor-{beta} signaling in tumor-reactive CD8(+) T cells activates the antitumor immune response cycle.
    Zhang Q; Yang XJ; Kundu SD; Pins M; Javonovic B; Meyer R; Kim SJ; Greenberg NM; Kuzel T; Meagher R; Guo Y; Lee C
    Mol Cancer Ther; 2006 Jul; 5(7):1733-43. PubMed ID: 16891459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.